title: Approach to the diagnosis and management of suspected exercise-induced bronchoconstriction by primary care physicians.
abstract: BACKGROUND
  Exercise-related respiratory symptoms in the diagnosis of exercise-induced bronchoconstriction (EIB) have poor predictive value. The aim of this study was to evaluate how athletes presenting with these symptoms are diagnosed and managed in primary care.
  
  
  METHODS
  An electronic survey was distributed to a random selection of family practitioners in England. The survey was designed to assess the frequency with which family practitioners encounter adults with exercise-related respiratory symptoms and how they would approach diagnostic work-up and management. The survey also evaluated awareness of and access to diagnostic tests in this setting and general knowledge of prescribing asthma treatments to competitive athletes.
  
  
  RESULTS
  257 family practitioners completed the online survey. One-third of respondents indicated they encountered individuals with this problem at a frequency of more than one case per month. Over two-thirds of family practitioners chose investigation as an initial management strategy, while one-quarter would initiate treatment based on clinical information alone. PEFR pre- and post-exercise was the most commonly selected test for investigation (44%), followed by resting spirometry pre- and post-bronchodilator (35%). Short-acting beta2-agonists were the most frequently selected choice of treatment indicated by respondents (90%).
  
  
  CONCLUSIONS
  Family practitioners encounter individuals with exercise-related respiratory symptoms commonly and although objective testing is often employed in diagnostic work-up, the tests most frequently utilised are not the most accurate for diagnosis of EIB. This diagnostic approach may be dictated by the reported lack of access to more precise testing methods, or may reflect a lack of dissemination or awareness of current evidence. Overall the findings have implications both for the management and hence welfare of athletes presenting with this problem to family practitioners and also for the competitive athletes requiring therapeutic use exemption.
authors.affiliation: School of Psychology & Sport Sciences, Northumbria University, Newcastle, UK. jiminio@doctors.org.uk
authors.forename: James H
authors.initials: JH
authors.lastname: Hull
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Hull
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Parsons
authors.forename: John W
authors.initials: JW
authors.lastname: Dickinson
authors.forename: Les
authors.initials: L
authors.lastname: Ansley
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000175:diagnosis* / Q000188:drug therapy*; D016084:Bronchoconstriction; D004739:England; D019538:Health Care Surveys; D006801:Humans; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care / Q000379:methods*; D013147:Spirometry; D013177:Sports
chemical_list: D018927:Anti-Asthmatic Agents